持续同调分析纵向CT纤维化特征在慢阻肺中的研究
本研究基于肺癌筛查队列(n=346)和两个前瞻性慢阻肺队列(京都大学n=234;京都-姬路n=166),利用持续同调(PH)技术量化CT上的纤维化病变,计算纤维化肺容积百分比(PH-fibrosis%)。结果显示PH-fibrosis%与间质性肺异常相关,且与未来急性加重风险独立相关(HR 1.39和3.35),并与死亡率相关(HR 1.94和1.86),纵向增加与急性加重频率和死亡率相关。
要点
- PH可量化CT纤维化病变,PH-fibrosis%与间质性肺异常相关
- 基线PH-fibrosis%高与未来急性加重风险独立相关
- PH-fibrosis%纵向增加与急性加重频率和死亡率相关
核心结论
- PH可用于量化CT上的纤维化病变,PH-fibrosis%可能成为慢阻肺患者的预后影像标志物。
研究设计与样本
- 研究纳入肺癌筛查队列(n=346)和两个前瞻性慢阻肺队列(京都大学n=234;京都-姬路n=166),基于CT值模式和空间拓扑用PH将每个体素分类为纤维化或非纤维化,计算PH-fibrosis%。
主要发现
- 在肺癌筛查和京都大学队列中,较高的PH-fibrosis%与间质性肺异常相关。
- 两个慢阻肺队列一致显示,较高的基线PH-fibrosis%与未来急性加重风险显著相关,独立于肺气肿和气道壁厚度(京都大学HR 1.39;京都-姬路HR 3.35)。
- 在京都大学队列中,较高的PH-fibrosis%与死亡率增加显著相关(HR 1.94),京都-姬路队列有类似趋势(HR 1.86)。
- 中位4.98年期间PH-fibrosis%的纵向增加与更高的急性加重频率相关,且PH-fibrosis%增加更大的患者随后死亡率更高(京都大学队列)。
临床怎么用
- PH-fibrosis%可作为慢阻肺患者预后评估的影像标志物,辅助识别急性加重和死亡高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fibrosis may coexist with emphysema in COPD, but computed tomography (CT) quantification is challenging. Persistent homology (PH), a topological data analysis technique, provides interpretable structural features in greyscale images. By using PH, this CT study aimed to quantify fibrotic lesions in nonemphysematous and emphysematous lungs and to investigate clinical implications of PH-based fibrosis quantification in patients with COPD. METHODS: The study included subjects from the Lung Cancer Screening (LCS) cohort (n=346) and two prospective COPD cohorts (Kyoto University n=234; Kyoto-Himeji n=166). Based on CT value patterns and spatial topology, PH assigned each voxel as fibrotic or nonfibrotic and calculated the percentage of fibrotic lung volume (PH-fibrosis%) in association with visually identified interstitial lung abnormality and COPD outcomes. RESULTS: Higher PH-fibrosis% was associated with interstitial lung abnormalities in the LCS and Kyoto University cohorts. The two COPD cohorts consistently showed significant associations between higher baseline PH-fibrosis% and future exacerbation risk independent of emphysema and airway wall thickness (hazard ratio (HR) 1.39 and 3.35 for Kyoto University and Kyoto-Himeji, respectively). In the Kyoto University cohort, higher PH-fibrosis% was significantly associated with increased mortality (HR 1.94), with a similar trend in the Kyoto-Himeji cohort (HR 1.86). Longitudinal increases in PH-fibrosis% over median 4.98 years were associated with higher exacerbation frequency and patients experiencing greater increase in PH-fibrosis% subsequently exhibited higher mortality in the Kyoto University cohort. CONCLUSIONS: PH can be used to quantify fibrotic lesions on CT and PH-fibrosis% could be a prognostic imaging marker in patients with COPD.
引用
- Shiraishi, Tanabe, Kaji, et al. Persistent homology analysis of longitudinal computed tomography fibrotic features in COPD. Eur Respir J. 2026. PMID: 41748284. doi:10.1183/13993003.01630-2025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。